Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Osteoporosis treatment by a new active vitamin D3 compound, eldecalcitol, in Japan.

Matsumoto T.

Curr Osteoporos Rep. 2012 Dec;10(4):248-50. doi: 10.1007/s11914-012-0116-1.

PMID:
22918710
2.

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.

Matsumoto T, Ito M, Hayashi Y, Hirota T, Tanigawara Y, Sone T, Fukunaga M, Shiraki M, Nakamura T.

Bone. 2011 Oct;49(4):605-12. doi: 10.1016/j.bone.2011.07.011. Epub 2011 Jul 19.

3.

[Active vitamin D3 analog].

Takata S.

Nihon Rinsho. 2015 Oct;73(10):1701-5. Japanese.

PMID:
26529933
4.

Eldecalcitol for the treatment of osteoporosis.

Noguchi Y, Kawate H, Nomura M, Takayanagi R.

Clin Interv Aging. 2013;8:1313-21. doi: 10.2147/CIA.S49825. Epub 2013 Sep 27. Review.

5.

Eldecalcitol for the treatment of osteoporosis.

Matsumoto T, Endo I.

Drugs Today (Barc). 2012 Mar;48(3):189-96. doi: 10.1358/dot.2012.48.3.1745223. Review.

PMID:
22462038
6.

Eldecalcitol: newly developed active vitamin D(3) analog for the treatment of osteoporosis.

Hagino H.

Expert Opin Pharmacother. 2013 Apr;14(6):817-25. doi: 10.1517/14656566.2013.778825. Epub 2013 Mar 11. Review.

PMID:
23477453
7.

Relationship between the effect of eldecalcitol and serum 25(OH)D level.

Takano T, Kondo S, Saito H, Matsumoto T; Eldecalcitol Study Group.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:124-7. doi: 10.1016/j.jsbmb.2013.11.005. Epub 2013 Nov 15.

8.

Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol.

Nakamura T, Takano T, Fukunaga M, Shiraki M, Matsumoto T.

J Bone Miner Metab. 2013 Jul;31(4):417-22. doi: 10.1007/s00774-012-0418-5. Epub 2013 Apr 11.

9.

Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis.

Hagino H, Takano T, Fukunaga M, Shiraki M, Nakamura T, Matsumoto T.

J Bone Miner Metab. 2013 Mar;31(2):183-9. doi: 10.1007/s00774-012-0397-6. Epub 2012 Nov 6.

10.

Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.

Matsumoto T, Takano T, Saito H, Takahashi F.

Bonekey Rep. 2014 Mar 5;3:513. doi: 10.1038/bonekey.2014.8. eCollection 2014. Review.

11.

Eldecalcitol reduces osteoporotic fractures by unique mechanisms.

Kondo S, Takano T, Ono Y, Saito H, Matsumoto T.

J Steroid Biochem Mol Biol. 2015 Apr;148:232-8. doi: 10.1016/j.jsbmb.2015.01.016. Epub 2015 Jan 24.

PMID:
25625663
12.

Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.

Ono Y.

J Steroid Biochem Mol Biol. 2014 Jan;139:88-97. doi: 10.1016/j.jsbmb.2013.10.007. Epub 2013 Oct 16. Review.

PMID:
24139874
13.

Eldecalcitol: a review of its use in the treatment of osteoporosis.

Sanford M, McCormack PL.

Drugs. 2011 Sep 10;71(13):1755-70. doi: 10.2165/11206790-000000000-00000. Review. Erratum in: Drugs. 2011 Dec 24;71(18):2390.

PMID:
21902297
14.

Vitamin D3 analogs for the treatment of osteoporosis.

Hagino H.

Can J Physiol Pharmacol. 2015 May;93(5):327-32. doi: 10.1139/cjpp-2014-0419. Epub 2015 Jan 28. Review.

PMID:
25853632
15.

[Current Topics on Vitamin D. Treatment of osteoporosis with eldecalcitol: Its therapeutic efficacy and adverse effect on renal function].

Takeuchi Y.

Clin Calcium. 2015 Mar;25(3):425-32. doi: CliCa1503425432. Review. Japanese.

PMID:
25716816
16.

Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials.

Xu Z, Fan C, Zhao X, Tao H.

Drug Des Devel Ther. 2016 Jan 28;10:509-17. doi: 10.2147/DDDT.S84264. eCollection 2016. Review. Erratum in: Drug Des Devel Ther. 2016;10:697.

17.

[Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].

Endo I, Matsumoto T.

Clin Calcium. 2011 Nov;21(11):103-10. doi: CliCa111116871694. Review. Japanese.

PMID:
22040826
18.
19.

Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.

Sakai A, Ito M, Tomomitsu T, Tsurukami H, Ikeda S, Fukuda F, Mizunuma H, Inoue T, Saito H, Nakamura T; e-ADVANCED Study Group.

Osteoporos Int. 2015 Mar;26(3):1193-202. doi: 10.1007/s00198-014-2991-z. Epub 2015 Jan 16. Erratum in: Osteoporos Int. 2015 Apr;26(4):1453.

20.

Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.

Takahashi N.

J Steroid Biochem Mol Biol. 2013 Jul;136:171-4. doi: 10.1016/j.jsbmb.2012.11.010. Epub 2012 Dec 5. Review.

PMID:
23220095

Supplemental Content

Support Center